New EV Tax Plans Raise Fleet Concerns

Alphabet is calling on the government to provide greater clarity over proposed changes to Electric Vehicle Excise Duty (eVED), warning that uncertainty around future taxation is making it more difficult for fleet operators to plan their transition to electric vehicles.

The leasing specialist believes the proposed introduction of eVED, alongside potential changes to Benefit-in-Kind taxation, could increase costs for businesses, create additional administrative burdens and ultimately slow the adoption of electric vehicles across commercial fleets.

Many lower-paid employees use Salary Sacrifice schemes to access electric vehicles, supporting wider fleet decarbonisation while helping to remove older, more polluting vehicles from the road. However, Alphabet warns that proposed tax changes could reduce affordability and limit access to the most cost-effective EVs.

Caroline Sandall-Mansergh, Alphabet’s Consultancy and Channel Development Manager, said:

We believe £15 to £30 will be added to monthly costs by eVED, so harming affordability and choice by potentially removing the cheapest vehicles from Salary Sacrifice schemes. Even small extra monthly costs can push vehicles out of reach, not just increasing prices but eliminating options entirely. The risk is that tax changes will remove this benefit for those it helps most, contradicting the government’s stated equity goals.

Alongside the financial impact, Alphabet believes the proposals would increase the administrative workload for fleet operators, leasing providers and drivers through additional mileage reporting and compliance requirements.

Sandall-Mansergh said:

There’s also going to be an administrative burden that comes with eVED, with mileage tracking through impractical manual odometer checks and reporting to reconcile expenditure. That’s going to increase complexity and costs for both fleet managers and individual drivers…

We know that balancing net-zero goals with budget constraints will remain a difficult challenge for the new Prime Minister, but a change of administration feels like the right time to review what’s been proposed and amend it to prioritise fairness and clarity. The current uncertainty – which has been echoed across the industry – complicates policy design and budget forecasting, risking wasted effort on strategies that may be undermined by changes further down the road. Long-term clarity is what’s needed, and now.

Alphabet also highlighted concerns that, if implemented as proposed, eVED would apply to all electric vehicles, including existing lease agreements, creating mid-contract cost increases for businesses and adding significant administrative complexity for leasing companies. The company warns that these additional costs are likely to be passed through the supply chain, increasing charges for fleet customers and potentially individual drivers.

As an alternative, Alphabet is advocating for a simpler taxation model that embeds EV taxation within charging costs, similar to the way fuel duty operates today. The company believes this would provide a fairer, mileage-based approach while reducing the administrative burden on fleet operators and supporting continued investment in zero-emission transport.

Listen Now: The “Silver Bullet” in Yard Optimisation

Warehouses have become smarter. Transport networks are more connected than ever. AI is rapidly reshaping planning and execution.

So why are so many logistics operations still relying on clipboards, phone calls and spreadsheets at one of the most critical points in the supply chain?

The answer might surprise you.

In the latest episode of Logistics Business Conversations, we uncover why one of logistics’ oldest operational challenges continues to cost businesses time, money and visibility—and why many organisations don’t realise how much it’s holding them back.

Our guest, Greg Braun from C3 Solutions shares insights from industry research that reveals a striking disconnect between what operators know needs to change and what actually happens on the ground. More importantly, we explore why solving these challenges isn’t about chasing the latest technology trend—it’s about fixing a problem that has been hiding in plain sight for decades.

If you’ve ever wondered why some distribution centres seem to flow effortlessly while others constantly battle congestion, delays and wasted resources, this conversation will make you look at your operation very differently.

And with autonomous vehicles, AI agents and increasingly connected supply chains on the horizon, the question isn’t whether the yard will evolve—it’s whether your business will be ready when it does.

🎧 Listen to the latest episode below and discover why the next competitive advantage in logistics might not be inside your warehouse at all.elayed shipments.

FedEx Launches Healthcare Delivery Company

FedEx Corp have announced the launch of FedEx Life Sciences, a dedicated organisation created to support the increasingly complex movement of pharmaceuticals, medical devices, biologics, clinical trials, and other critical healthcare shipments.

As medicine becomes more specialised, global, and time-sensitive, life sciences companies need logistics networks built for precision, visibility, and reliability. From temperature-sensitive therapies and clinical trial materials to medical devices and patient-critical shipments, healthcare supply chains now require specialised support across highly regulated markets.

FedEx Life Sciences brings together the strength of the FedEx global network with a dedicated healthcare team and advanced monitoring capabilities to serve pharmaceutical and healthcare professionals working to deliver care to patients around the world.

As part of the launch, Nick Gennari will exclusively focus on this segment as president of healthcare and life sciences. Gennari joined FedEx in 1992 and has spent much of his more than 30-year tenure driving strategic sales and supply chain solutions for global healthcare, aerospace, and high-tech customers, before assuming leadership of the healthcare vertical in 2024. His appointment to lead this newly specialized organisation reflects the FedEx commitment to pairing deep, long-standing sector expertise with its global logistics and technological capabilities. Gennari and his team’s efforts have been instrumental in growing FedEx healthcare revenue to approximately $10 billion globally. 

Healthcare depends on access, and access depends on certainty… Every shipment we move in this space has the potential to support a researcher, a physician, a clinician, a caregiver, or most importantly, a patient waiting for care. FedEx Life Sciences brings together our global network, advanced monitoring capabilities, and healthcare-focused expertise to help make supply chains smarter and more resilient. Under Nick’s leadership, this organization will help healthcare customers move with the speed, confidence, and precision patients require.

said Brie Carere, executive vice president and chief customer officer, FedEx.

FedEx Life Sciences builds on significant investments the company has made in healthcare infrastructure and technology. In 2025, FedEx secured IATA CEIV Pharma Corporate Certification, achieving corporate-level certification for ground handling across its air hubs and ramps. In addition, FedEx recently appointed a vice president of global quality, healthcare, and life sciences to oversee global quality management systems for the organisation and support the standards required by pharmaceutical and medical device manufacturers.

FedEx has also expanded its life sciences footprint with a total of six Life Sciences Centers globally. Additionally, a direct flight between Indianapolis and Dublin has strengthened transatlantic connectivity between these two critical pharmaceutical manufacturing hubs, as the company continues to connect global pharmaceutical epicenters. 

These assets are supported by FedEx Surround, a monitoring and intervention service that uses machine learning to provide proactive, end-to-end visibility for critical shipments, identify potential disruptions, and support intervention when timing, temperature, and reliability are essential.

Healthcare supply chains are becoming more complex, and the stakes are deeply personal… FedEx Life Sciences gives our customers a more focused team, stronger coordination, and specialized expertise to help them move critical healthcare shipments with confidence. Our role is to provide the certainty, visibility, and global reach healthcare innovators need when every shipment matters.

said Nick Gennari, president of healthcare and life sciences, FedEx.

Subscribe

Get notified about New Episodes of our Podcast, New Magazine Issues and stay updated with our Weekly Newsletter.